Friday, June 27, 2025 | 10:21 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

iNCOVACC: All you need to know about world's first intranasal Covid vaccine

The vaccine been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India

Bharat Biotech’s iNCOVACC, Bharat Bio’s nasal Covid vaccine, nasal Covid vaccine, Covid vaccine
premium

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus.

BS Web Team New Delhi
India launched its first intranasal Covid-19 vaccine named iNCOVACC, on Thursday, January 26. Manufactured by Hyderabad-based Bharat Biotech, the intranasal vaccine was launched by Union Health Minister Mansukh Mandaviya and Union Minister of Science & Technology Jitendra Singh on India's 74th Republic Day.

The vaccine has been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India.

Here's everything you need to know about India's first intranasal vaccine for coronavirus:

What is iNCOVACC?

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus. According to